Linked Life Data

18279705

Source:http://linkedlifedata.com/resource/pubmed/id/18279705

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-2-18
pubmed:abstractText
The -374T/A polymorphism of the Receptor for Advanced Glycation End products (RAGE) may exert a protective effect toward the development of atherosclerosis. No data are currently available on the potential prognostic role of this polymorphism in patients with angiographically proven coronary artery disease (CAD). Hereto we sought to address this issue in a large consecutive cohort of patients undergoing coronary revascularization.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0188-4409
pubmed:author
pubmed:issnType
Print
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
320-5
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease.
pubmed:affiliation
Department of Cardiology, University Hospital Fondazione IRCCS San Matteo, Pavia, Italy; Interdepartmental Center for Research in Prevention of Cardiovascular and Metabolic Disorders (CIRMC), University of Pavia, Pavia, Italy.
pubmed:publicationType
Journal Article